Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.
J Clin Endocrinol Metab. 2012 Sep;97(9):3068-78. doi: 10.1210/jc.2012-1616. Epub 2012 Jul 31.
Central hypothyroidism (CH) is a particular hypothyroid condition due to an insufficient stimulation by TSH of an otherwise normal thyroid gland. This condition raises several challenges for clinicians; therefore, a review of the most relevant findings on CH epidemiology, pathogenesis, and clinical management has been performed.
The relevant papers were selected by a PubMed search using appropriate key words.
CH can be the consequence of various disorders affecting either the pituitary gland or the hypothalamus, but most frequently affecting both of them. CH is about 1000-fold rarer than primary hypothyroidism. Except for the neonatal CH due to biallelic TSHβ mutations, the thyroid hormone defect is rarely as profound as can be observed in some primary forms. In contrast with primary hypothyroidism, CH is most frequently characterized by low/normal TSH levels, and adequate thyroid hormone replacement is associated with the suppression of residual TSH secretion. Thus, CH often represents a clinical challenge because physicians cannot rely on the systematic use of the "reflex TSH strategy." The clinical management of CH is further complicated by the frequent combination with other pituitary deficiencies and their substitution.
中枢性甲状腺功能减退症(CH)是一种特殊的甲状腺功能减退症,其原因是 TSH 对正常甲状腺的刺激不足。这种情况给临床医生带来了诸多挑战;因此,对 CH 的流行病学、发病机制和临床管理的最相关发现进行了综述。
通过使用适当的关键词在 PubMed 上进行搜索,选择了相关的论文。
CH 可能是影响垂体或下丘脑的各种疾病的结果,但最常影响两者。CH 比原发性甲状腺功能减退症罕见约 1000 倍。除了由于 TSHβ 突变导致的新生儿 CH 外,甲状腺激素缺陷很少像一些原发性疾病那样严重。与原发性甲状腺功能减退症不同,CH 最常见的特征是 TSH 水平低/正常,并且适当的甲状腺激素替代与残余 TSH 分泌的抑制有关。因此,CH 经常代表一个临床挑战,因为医生不能依赖于系统使用“反射 TSH 策略”。CH 的临床管理因与其他垂体功能减退症的频繁组合及其替代而变得更加复杂。